SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001461993-19-000059
Filing Date
2019-11-12
Accepted
2019-11-12 16:58:33
Documents
81
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q Q3 2019 mlnt-093019x10q.htm 10-Q 1072930
2 EXHIBIT 31.1 mlnt-093019ex311.htm EX-31.1 14078
3 EXHIBIT 31.2 mlnt-093019ex312.htm EX-31.2 13972
4 EXHIBIT 32.1 mlnt-093019ex321.htm EX-32.1 8104
5 EXHIBIT 32.2 mlnt-093019ex322.htm EX-32.2 7863
  Complete submission text file 0001461993-19-000059.txt   8161723

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT mlnt-20190930.xml EX-101.INS 1817403
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mlnt-20190930.xsd EX-101.SCH 58831
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mlnt-20190930_cal.xml EX-101.CAL 95995
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mlnt-20190930_def.xml EX-101.DEF 429167
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mlnt-20190930_lab.xml EX-101.LAB 759967
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mlnt-20190930_pre.xml EX-101.PRE 536880
Mailing Address 44 WHIPPANY ROAD MORRISTOWN NJ 07963
Business Address 44 WHIPPANY ROAD MORRISTOWN NJ 07963 908 617-1309
MELINTA THERAPEUTICS, INC. /NEW/ (Filer) CIK: 0001461993 (see all company filings)

IRS No.: 454440364 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35405 | Film No.: 191210527
SIC: 2834 Pharmaceutical Preparations